Orthotopic liver transplantation for hereditary fibrinogen amyloidosis

Transplantation

Volumn 75, Issue 4, 2003, Pages 560-561

  Zeldenrust, S ^a   Gertz, M ^a   Uemichi, T ^b   Bjornsson J ^c   Wiesner, R ^c   Schwab, T ^c   Benson, M ^b  

^a MAYO CLINIC   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; IMMUNOGLOBULIN LAMBDA CHAIN; PREALBUMIN;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GENETIC DISORDER; HUMAN; HUMAN TISSUE; HYPERKALEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; NAUSEA; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEINURIA; SYMPTOM; TREATMENT OUTCOME; VOMITING;

AMYLOIDOSIS, FAMILIAL; FAMILY HEALTH; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0037468499     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000046526.10003.EC     Document Type: Article

References (17)

1. Benson MD, Liepnieks J, Uemichi T, et al. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain [see comments]. Knead Genet 1993; 3(3): 252.
2. Uemichi T, Liepnieks JJ, Benson MD. Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 1994; 93(2): 731.
3. Uemichi T, Liepnieks JJ, Yamada T, et al. A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis. Blood 1996; 87(10): 4197.
4. Uemichi T, Liepnieks JJ, Gertz MA, et al. Fibrinogen A alpha chain Leu 554: an African-American kindred with late onset renal amyloidosis. Amyloid 1998; 5(3): 188.
5. Hamidi Asl L, Liepnieks JJ, Uemichi T, et al. Renal amyloidosis with a frame shift mutation in fibrinogen a alpha-chain gene producing a novel amyloid protein. Blood 1997; 90(12): 4799.
6. Mutsuda M. Molecular abnormalities of fibrinogen: the present status of structure elucidation. In: Matsuda M, Iwanage S, Takada A, and Henschen A, eds. Fibrinogen 4: Current basic and clinical aspects. Amsterdam: Excerpta Medica 1990, p 139.
7. Holmgren G, Steen L, Ekstedt J, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991; 40(3): 242.
8. Dubrey SW, Davidoff R, Skinner M, et al. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997; 64(1): 74.
9. Garcia-Herola A, Prieto M, Pascual S, et al. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 1999; 5(3): 246.
10. Gillmore JD, Stangou AJ, O'Grady J, et al. Possible progressive CNS amyloidosis following liver transplantation for FAP. Presented at the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders. Umea, Sweden, June 5, 1999.
11. Munar-Ques M, Salva-Ladaria L, Mulet-Perera P, et al. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000; 7(4): 266.
12. Stangou AJ, Hawkins PN, Heaton ND, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998; 66(2): 229.
13. Gillmore JD, Stangou AJ, Tennent GA, et al. Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation 2001; 71(7): 986.
14. Gillmore JD, Booth DR, Rela M, et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. QJM 2000; 93(5): 269.
15. Heering P, Hetzel R, Grabensee B, et al. Renal transplantation in secondary systemic amyloidosis. Clin Transpl 1998; 12(3): 159.
16. Nishikido M, Koga S, Kanetake H, et al. Renal transplantation in systemic amyloidosis. Clin Transpl 1999; 13(suppl 1): 63.
17. Bleyer AJ, Donaldson LA, McIntosh M, et al. Relationship between underlying renal disease and renal transplantation outcome. Am J Kidney Dis 2001; 37(6): 1152.